Biotage Logo
SE0000454746
A0MNB5
BIOT.ST

Biotage

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2025, Biotage has already paid €0.15 in dividends. The last payout was in May 2025.

Financials

In the last year, Biotage had revenue of €178.57M and net profit of €24.67M
(EUR) 2024
YoY
Revenue 178.57M 6.95%
Gross profit 111.95M 23.25%
Net profit 24.67M 11.82%
EBITDA 46.03M 5.41%

Fundamentals

Metric Value
Market capitalization
€1.04B
Number of shares
80.05M
52-week high/low
€18.38 - €7.42
Dividends No
Beta
0.85
P/E ratio
40.34
PEG ratio
6.77
P/B ratio
2.79
P/S ratio
5.58

Company profile

Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Name
Biotage
CEO
Frederic Vanderhaegen
Headquarters Uppsala,
Sweden
Website
Sector
Health Care
Industry
Biotechnology
IPO
06/30/2000
Employees 622

Ticker symbols

Exchange Symbol
Sto
BIOT.ST
Pnk
BITGF
Frankfurt
PQX1.F
Düsseldorf
PQX1.DU
London
0GRP.L
Stockholm
BIOT.ST
München
PQX1.MU
🍪

Parqet  uses cookies. Learn more